Blacksmith Medicines to Present Groundbreaking Oncology Research at AACR Annual Meeting 2026 Blacksmith Medicines will showcase its innovative oncology program focusing on FEN1 at the AACR Annual Meeting 2026 in San Diego, CA.

Blacksmith Medicines to Present Groundbreaking Oncology Research at AACR Annual Meeting 2026 #United_States #San_Diego #Blacksmith_Medicines #oncology_research #FEN1

Dr. Nancy L. Lewis Appointed Chief Scientific Officer at NCCN Dr. Nancy L. Lewis has been appointed as the Chief Scientific Officer of the National Comprehensive Cancer Network, enhancing oncology research and care.

Dr. Nancy L. Lewis Appointed Chief Scientific Officer at NCCN #USA #Plymouth_Meeting #NCCN #oncology_research #Dr._Nancy_L._Lewis

Perceptive Discovery Unveils Expansion in Preclinical Oncology Research Capabilities Perceptive Discovery enhances its Needham, MA lab capabilities, significantly advancing preclinical oncology research through a strategic expansion.

Perceptive Discovery Unveils Expansion in Preclinical Oncology Research Capabilities #United_States #Biopharmaceutical #Needham #oncology_research #Perceptive_Discovery

Jazz Pharmaceuticals Unveils Groundbreaking Clinical Advances in Oncology at AACR 2026 Jazz Pharmaceuticals is set to present key clinical findings at AACR 2026, including advancements in HER2-targeted treatments and promising preclinical data on new oncology compounds.

Jazz Pharmaceuticals Unveils Groundbreaking Clinical Advances in Oncology at AACR 2026 #Ireland #Dublin #Jazz_Pharmaceuticals #oncology_research #AACR_2026

The Growing BCL-2 Inhibitors Market: Key Trends and Prognosis for 2025-2034 The BCL-2 inhibitors market is on the rise, driven by increasing cancer cases and the advent of innovative therapies. Discover how this sector is shaping up until 2034.

The Growing BCL-2 Inhibitors Market: Key Trends and Prognosis for 2025-2034 #United_States #Las_Vegas #Cancer_Treatment #oncology_research #BCL-2_Inhibitors

Pierre Fabre Laboratories and Iktos Collaborate on AI-Driven Drug Discovery for Oncology Pierre Fabre Laboratories and Iktos have announced a groundbreaking collaboration aimed at integrating AI for drug discovery in oncology, focusing on developing new low-molecular-weight drug candidates.

Pierre Fabre Laboratories and Iktos Collaborate on AI-Driven Drug Discovery for Oncology #France #Pierre_Fabre #Iktos #oncology_research #Castres

Florida Cancer Specialists Innovate in Gastrointestinal Cancer Research at Global Forum Florida Cancer Specialists & Research Institute advances gastrointestinal cancer research through global collaboration, enhancing patient care and treatment strategies.

Florida Cancer Specialists Innovate in Gastrointestinal Cancer Research at Global Forum #USA #Florida_Cancer_Specialists #Fort_Myers #oncology_research #Gastrointestinal_Cancer

Global MiRNA Microarray Kits and Reagents Market Expected to Reach USD 2.45 Billion by 2033 Driven by 8.5% CAGR Growth The MiRNA microarray kits and reagents market is set to reach USD 2.45 billion by 2033, fueled by an 8.5% CAGR, highlighting increasing demand for precision diagnostics.

Global MiRNA Microarray Kits and Reagents Market Expected to Reach USD 2.45 Billion by 2033 Driven by 8.5% CAGR Growth #None #Precision_Diagnostics #oncology_research #MiRNA_Microarray_Kits

Hengrui Pharma Shines at ESMO 2025 with Its Groundbreaking Oncology Innovations At the ESMO 2025 Congress, Hengrui Pharma unveiled 46 innovative studies, solidifying its role in global oncology research and patient care.

Hengrui Pharma Shines at ESMO 2025 with Its Groundbreaking Oncology Innovations #Germany #Berlin #Hengrui_Pharma #oncology_research #ESMO_Congress

Cancer Drugs Market Forecasted to Surpass $516 Billion by 2031 Driven by Robust Oncology Research Investments The cancer drugs market is expected to reach $516.15 billion by 2031, driven by increased research investments and rising cancer prevalence.

Cancer Drugs Market Forecasted to Surpass $516 Billion by 2031 Driven by Robust Oncology Research Investments #None #pharmaceutical #oncology_research #cancer_drugs

IDEAYA Biosciences Unveils Exciting Agenda for 10-Year R&D Anniversary Celebration IDEAYA Biosciences is set to mark its 10-year anniversary with an R&D Day on September 8, 2025, featuring key clinical data presentations and growth strategies.

IDEAYA Biosciences Unveils Exciting Agenda for 10-Year R&D Anniversary Celebration #USA #New_York #IDEAYA_Biosciences #darovasertib #oncology_research

Accelerating Oncology Trials: START and Advarra Unite to Enhance Efficiency and Quality Discover how the partnership between START and Advarra is transforming early-phase oncology trials with improved speed, quality, and patient-centric approaches.

Accelerating Oncology Trials: START and Advarra Unite to Enhance Efficiency and Quality #USA #San_Antonio #Advarra #oncology_research #START_Center

The Future of ROR Inhibitors: Insights into Market Growth Trends and Innovations Through 2034 The ROR inhibitors market is set for substantial growth, driven by advancements in oncology research and an expanding pipeline of therapies. This article explores key trends and emerging therapies that will shape the future of the market.

The Future of ROR Inhibitors: Insights into Market Growth Trends and Innovations Through 2034 #USA #Las_Vegas #oncology_research #ROR_Inhibitors #Therapeutic_Innovations

Whitehawk Therapeutics to Join H.C. Wainwright 'HCW@Home' Series for Virtual Event Whitehawk Therapeutics will engage in the H.C. Wainwright 'HCW@Home' virtual series, showcasing their advanced oncology solutions on June 26, 2025.

Whitehawk Therapeutics to Join H.C. Wainwright 'HCW@Home' Series for Virtual Event #United_States #Morristown #oncology_research #Whitehawk_Therapeutics #ADC_cancer_treatments

Veeva Systems and Sarah Cannon Research Institute Unite to Enhance Clinical Oncology Studies Veeva and Sarah Cannon Research Institute announce a strategic collaboration to boost efficiency in clinical oncology studies across 200 research sites.

Veeva Systems and Sarah Cannon Research Institute Unite to Enhance Clinical Oncology Studies #USA #Nashville #Veeva_Systems #oncology_research #Sarah_Cannon

Blacksmith Medicines to Present Promising FEN1 Research at AACR 2025 Meeting Blacksmith Medicines is set to unveil significant findings related to its oncology program targeting FEN1 at the AACR Annual Meeting 2025 in Chicago.

Blacksmith Medicines to Present Promising FEN1 Research at AACR 2025 Meeting #United_States #Chicago #Blacksmith_Medicines #oncology_research #FEN1

Four Innovative Projects Awarded Complete Genomics' Spatial Xcellerator Grant Complete Genomics has awarded its Spatial Xcellerator Grant to four innovative research projects focusing on critical health issues. Discover the winners and their impactful research.

Four Innovative Projects Awarded Complete Genomics' Spatial Xcellerator Grant #United_States #San_Jose #Complete_Genomics #oncology_research #Spatial_Xcellerator

Celebrating the Future of Cancer Research: NCCN Foundation Awards Young Investigators The NCCN Foundation awards four promising oncology researchers, revolutionizing cancer treatment. Each recipient receives up to $150,000 to support innovative studies.

Celebrating the Future of Cancer Research: NCCN Foundation Awards Young Investigators #United_States #Cancer_Treatment #Plymouth_Meeting #oncology_research #NCCN_Foundation

AbbVie Unveils Promising Oncological Research Findings at AACR 2025 Meeting At AACR 2025, AbbVie showcases pioneering cancer research, revealing significant advancements with novel therapies targeting complex tumors and minimally addressed needs.

AbbVie Unveils Promising Oncological Research Findings at AACR 2025 Meeting #United_States #AbbVie #North_Chicago #oncology_research #AACR

Florida Cancer Specialists to Highlight Blood Cancer Research at California Oncology Conference Florida Cancer Specialists will present groundbreaking research on blood cancer management at the MOASC 2025 Annual Oncology Summit, focusing on patient outcomes.

Florida Cancer Specialists to Highlight Blood Cancer Research at California Oncology Conference #USA #Florida_Cancer_Specialists #Fort_Myers #Blood_Cancer #oncology_research

Advarra Launches Oncology Research Pulse to Enhance Cancer Trials and Collaboration Advarra introduces Oncology Research Pulse, a pioneering initiative aimed at streamlining cancer research by fostering collaboration and knowledge sharing among industry stakeholders.

Advarra Launches Oncology Research Pulse to Enhance Cancer Trials and Collaboration #USA #Clinical_Trials #Columbia #Advarra #oncology_research

Discovery Life Sciences Unveils Tumoroids at Precision Med Tri-Con in San Diego Discovery Life Sciences announces the launch of Tumoroid cell lines at Precision Med Tri-Con in San Diego, enhancing oncology research capabilities.

Discovery Life Sciences Unveils Tumoroids at Precision Med Tri-Con in San Diego #USA #San_Diego #oncology_research #Tumoroids #Discovery_Life_Sciences

Discovery Life Sciences Set to Unveil Revolutionary Tumoroids at Precision Med Tri-Con in San Diego At the upcoming Precision Med Tri-Con, Discovery Life Sciences will unveil new tumoroid cell lines designed to accelerate oncology research and improve treatment outcomes.

Discovery Life Sciences Set to Unveil Revolutionary Tumoroids at Precision Med Tri-Con in San Diego #USA #San_Diego #oncology_research #Tumoroids #Discovery_Life_Sciences

Marengo Therapeutics Welcomes Dr. Elena Garralda to Its Scientific Advisory Board in 2025 Marengo Therapeutics has appointed Dr. Elena Garralda to its Scientific Advisory Board, enhancing its oncology strategy and research efforts.

Marengo Therapeutics Welcomes Dr. Elena Garralda to Its Scientific Advisory Board in 2025 #USA #Cambridge #Marengo_Therapeutics #Elena_Garralda #oncology_research